
Ep. 372 - Biotech IPOs, Biosecure Act, cachexia pipeline
Jun 15, 2026 - 25:13
Radio and PodcastLive Radio & Podcasts
Biotech has been resilient as the financial markets teeter under global volatility. For now, M&A and financings, if not IPOs, are continuing, but will the Mideast conflict halt biotech’s recovery? On the latest BioCentur...
Ep. 359 - 2Q markets preview, tariffs and biotech takeouts is an episode from BioCentury This Week by BioCentury. Biotech has been resilient as the financial markets teeter under global volatility. For now, M&A and financings, if not IPOs,...
This episode belongs to BioCentury This Week.
Use the player on this page to stream the episode online.
Published Apr 7, 2026, 38:41 long, audio available.